Long-acting capsid inhibitor protects macaques from repeat SHIV challenges

Because no currently available vaccine can prevent HIV infection, pre-exposure prophylaxis (PrEP) with antiretrovirals (ARVs) is an important tool for combating the HIV pandemic(1,2). Long-acting ARVs promise to build on the success of current PrEP strategies, which must be taken daily, by reducing...

Descripción completa

Detalles Bibliográficos
Autores principales: Vidal, Samuel J., Bekerman, Elena, Hansen, Derek, Lu, Bing, Wang, Kelly, Mwangi, Judy, Rowe, William, Campigotto, Federico, Zheng, Jim, Kato, Darryl, Chandrashekar, Abishek, Barrett, Julia, Patel, Shivani, Wan, Huahua, Anioke, Tochi, Mercado, Noe B., Nkolola, Joseph P., Ferguson, Melissa J., Rinaldi, William J., Callebaut, Christian, Blair, Wade, Cihlar, Tomas, Geleziunas, Romas, Yant, Stephen R., Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753592/
https://www.ncbi.nlm.nih.gov/pubmed/34875675
http://dx.doi.org/10.1038/s41586-021-04279-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753592/
https://www.ncbi.nlm.nih.gov/pubmed/34875675
http://dx.doi.org/10.1038/s41586-021-04279-4

Ejemplares similares